Systematic analysis of natural topoisomerase I inhibitors from <i>Forsythiae Fructus</i> by ultrafiltration-UPLC-ESI-MS/MS, pharmacophore modelling, and molecular dynamics simulation
This study conducted a systematic analysis to explore natural DNA topoisomerase I (topo I) inhibitors from <i>Forsythiae Fructus</i> (<i>FF</i>). Crude extract of <i>FF</i> exhibited notable toxic and anti-proliferative effects on A549 cells. A total of 36 components were identified using bioaffinity ultrafiltration UPLC-ESI-MS/MS. Pinoresinol, 1,8-dihydrox-yanthraquinone, quercetin, and lariciresinol were screened as topo I inhibitors. Their ESI fragmentation patterns were analysed. An obvious repair effect on damaged DNA strands was observed by topo I inhibitory binding assay. Moreover, a common feature-based pharmacophore model was constructed and another 7 topo I inhibitors were screened. Molecular docking indicated that hydrogen bond, π-anion, and π-alkyl interaction were major interactions. Molecular dynamics simulation revealed important residues determining the binding of amentoflavone, forsythoside B and topo I. The results improved current understanding of natural topo I inhibitors from <i>FF</i>. Moreover, the combination of multi-disciplinary approaches provided a new tool to investigate natural antitumor products.
Authors
- Z. X. Li
- Jianzhao Qi (ORCID: https://orcid.org/0000-0003-1418-873X)
- Shiping Zhang (ORCID: https://orcid.org/0000-0001-9329-8894)
- Lu Jia (ORCID: https://orcid.org/0000-0001-5248-9504)
- Jingbo Hu (ORCID: https://orcid.org/0000-0002-9121-0489)
- Nana Tan
- Huan Wang (ORCID: https://orcid.org/0000-0003-3836-0741)
- Xiaoling Wang (ORCID: https://orcid.org/0000-0001-9985-8354)
- Le Wang (ORCID: https://orcid.org/0000-0003-2107-2743)
- Tian Wang (ORCID: https://orcid.org/0000-0002-6049-006X)
Institutions
- Baoji University of Arts and Sciences (CN)
- Northwest A&F University (CN)
Publication Details
- Journal
- Natural Product Research
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1080/14786419.2024.2425055
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China